Cargando…
Characterization of Brevibacillus laterosporus Cas9 (BlatCas9) for Mammalian Genome Editing
Compact CRISPR/Cas9 systems that can be delivered by AAV for in vivo genome editing hold great promise for clinical applications. Brevibacillus laterosporus Cas9 (BlatCas9) is a compact Cas9 nuclease that has been identified for plant genome editing. Here, we characterize BlatCas9 as an alternative...
Autores principales: | Gao, Ning, Zhang, Chengdong, Hu, Ziying, Li, Miaomiao, Wei, Jingjing, Wang, Yongming, Liu, Huihui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7604293/ https://www.ncbi.nlm.nih.gov/pubmed/33195228 http://dx.doi.org/10.3389/fcell.2020.583164 |
Ejemplares similares
-
Brevibacillus Laterosporus Bacteremia in an Adult
por: Curtis, Anna K, et al.
Publicado: (2020) -
A compact Cas9 ortholog from Staphylococcus Auricularis (SauriCas9) expands the DNA targeting scope
por: Hu, Ziying, et al.
Publicado: (2020) -
Opportunities for CRISPR/Cas9 Gene Editing in Retinal Regeneration Research
por: Campbell, Leah J., et al.
Publicado: (2017) -
Enhancing Understanding of the Visual Cycle by Applying CRISPR/Cas9 Gene Editing in Zebrafish
por: Ward, Rebecca, et al.
Publicado: (2018) -
The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Inherited Diseases
por: Abdelnour, Sameh A., et al.
Publicado: (2021)